Phase II single-arm, single-institution trial of neoadjuvant gemcitabine and oxaliplatin treatment (NT) in patients (pts) with resectable pancreas adenocarcinoma (PC)

被引：0
|
作者：
O'Reilly, E. M.
Jarnagin, W. R.
Brennan, M. F.
Winston, C.
Tang, L. H.
Capanu, M.
Schattner, M.
Chen, L. Y.
DeMatteo, R. P.
DiMaio, C. J.
D'Angelica, M. I.
Kurtz, R. C.
Klimstra, D. S.
Lowery, M. A.
Coit, D. G.
Reidy, D. L.
Allen, P. J.
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA
[3] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.4065
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4065
引用
收藏
页数：1
相关论文
共 50 条
  • [41] A multicenter, open-label, single-arm phase I trial of neoadjuvant nivolumab monotherapy for resectable gastric cancer
    Hasegawa, Hirotaka
    Shitara, Kohei
    Takiguchi, Shuji
    Takiguchi, Noriaki
    Ito, Seiji
    Kochi, Mitsugu
    Horinouchi, Hidehito
    Kinoshita, Takahiro
    Yoshikawa, Takaki
    Muro, Kei
    Nishikawa, Hiroyoshi
    Suna, Hideaki
    Kodera, Yasuhiro
    GASTRIC CANCER, 2022, 25 (03) : 619 - 628
  • [42] A multicenter, open-label, single-arm phase I trial of neoadjuvant nivolumab monotherapy for resectable gastric cancer
    Hirotaka Hasegawa
    Kohei Shitara
    Shuji Takiguchi
    Noriaki Takiguchi
    Seiji Ito
    Mitsugu Kochi
    Hidehito Horinouchi
    Takahiro Kinoshita
    Takaki Yoshikawa
    Kei Muro
    Hiroyoshi Nishikawa
    Hideaki Suna
    Yasuhiro Kodera
    Gastric Cancer, 2022, 25 : 619 - 628
  • [43] INFINITY: A multicentre, single-arm, multi-cohort, phase II trial of tremelimumab and durvalumab as neoadjuvant treatment of patients with microsatellite instability-high (MSI) resectable gastric or gastroesophageal junction adenocarcinoma (GAC/GEJAC).
    Pietrantonio, Filippo
    Raimondi, Alessandra
    Lonardi, Sara
    Murgioni, Sabina
    Cardellino, Giovanni Gerardo
    Tamberi, Stefano
    Strippoli, Antonia
    Palermo, Federica
    Prisciandaro, Michele
    Randon, Giovanni
    Corti, Francesca
    Bergamo, Francesca
    Nappo, Floriana
    Leone, Alberto Giovanni
    Leoncini, Giuseppe
    Sabella, Giovanna
    Kaneva, Kristiyana
    Sposito, Carlo
    Di Bartolomeo, Maria
    Mazzaferro, Vincenzo
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 358 - 358
  • [44] CapOX as neoadjuvant chemotherapy for locally advanced operable colon cancer patients: a prospective single-arm phase II trial
    Liu, Fangqi
    Yang, Li
    Wu, Yuchen
    Li, Cong
    Zhao, Jiang
    Keranmu, Adili
    Zheng, Hongtu
    Huang, Dan
    Wang, Lei
    Tong, Tong
    Xu, Junyan
    Zhu, Ji
    Cai, Sanjun
    Xu, Ye
    CHINESE JOURNAL OF CANCER RESEARCH, 2016, 28 (06) : 589 - 597
  • [45] Quality of Life in a Prospective, Multicenter Phase 2 Trial of Neoadjuvant Full-Dose Gemcitabine, Oxaliplatin, and Radiation in Patients With Resectable or Borderline Resectable Pancreatic Adenocarcinoma
    Serrano, Pablo E.
    Herman, Joseph M.
    Griffith, Kent A.
    Zalupski, Mark M.
    Kim, Edward J.
    Bekaii-Saab, Tanios S.
    Ben-Josef, Edgar
    Dawson, Laura A.
    Ringash, Jolie
    Wei, Alice C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 (02): : 270 - 277
  • [46] Phase II trial of neoadjuvant full-dose gemcitabine, oxaliplatin, and radiation (RT) in patients with resectable (R) or borderline resectable (BR) pancreatic cancer
    Kim, E. J.
    Ben-Josef, E.
    Griffith, K. A.
    Herman, J. M.
    Wolfgang, C. L.
    Bekaii-Saab, T. S.
    Bloomston, M.
    Dawson, L. A.
    Moore, M. J.
    Zalupski, M. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [47] Efficacy and safety of S-1 plus oxaliplatin combined with apatinib and camrelizumab as neoadjuvant therapy for patients with locally advanced gastric or gastroesophageal junction adenocarcinoma: a protocol for a single-arm phase II trial
    Chang, Chen
    Cai, Zhaolun
    Cheng, Ke
    Shen, Chaoyong
    Zhang, Bo
    Chen, Zhixin
    Yin, Yuan
    Cao, Dan
    UPDATES IN SURGERY, 2025, 77 (01) : 165 - 174
  • [48] A prospective single-center, single-arm, open-label, phase II study of sintilimab and anlotinib combined with chemotherapy in neoadjuvant treatment of resectable esophageal cancer
    Duan, Hongtao
    Wang, Zhaoyang
    Cao, Lili
    Zhu, Yifang
    Tong, Liping
    Yan, Xiaolong
    THORACIC CANCER, 2024, 15 (19) : 1471 - 1476
  • [49] Trifluridine/tipiracil (FTD/TPI) in patients with fluoropyrimidine refractory advanced pancreatic adenocarcinoma: A single-arm phase II trial
    Chiang, C-L.
    Chan, S. K.
    Lee, A. S.
    Wong, C. Y.
    Chan, D.
    Chiu, W. H. K.
    Lo, R.
    ANNALS OF ONCOLOGY, 2024, 35 : S138 - S138
  • [50] Neoadjuvant toripalimab plus chemotherapy in patients with potentially resectable non-small cell lung cancer: A prospective, single-arm, phase II trial (Renaissance Study)
    Yan, S.
    Chen, J.
    Wang, J.
    Lv, C.
    Bi, J.
    Yang, X.
    Li, S.
    Wang, Y.
    Li, X.
    Yang, Y.
    Wu, N.
    ANNALS OF ONCOLOGY, 2021, 32 : S1400 - S1400
12345